Skip to main content
logo
Algorae Pharmaceuticals Limited (ASX:1AI)
Australia flag Australia · Delayed Price · Currency is AUD
0.0090
0.00 (0.00%)
Sep 18, 2026, 2:45 PM AEST

Algorae Pharmaceuticals Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
3.190.470.812.094.24
Short-Term Investments
0.751.852.32.02-
Cash & Short-Term Investments
3.942.323.114.114.24
Cash Growth
69.77%-25.39%-24.39%-3.02%162.92%
Accounts Receivable
000.030.01-
Other Receivables
0.080.040.010.090.03
Receivables
0.080.040.040.10.03
Inventory
0.18----
Other Current Assets
0.240.040.04--
Total Current Assets
4.442.43.194.214.27
Property, Plant & Equipment
---00.01
Total Assets
4.442.43.194.214.27

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
0.090.070.120.180.05
Accrued Expenses
0.090.10.060.270.15
Other Current Liabilities
----0.04
Total Current Liabilities
0.180.170.180.450.24
Total Liabilities
0.180.170.180.450.24

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
85.4781.5481.5480.2478.95
Retained Earnings
-82.06-79.89-79.08-80.73-78.74
Comprehensive Income & Other
0.850.570.564.253.83
Shareholders' Equity
4.262.233.013.764.03
Total Liabilities & Equity
4.442.43.194.214.27

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash (Debt)
3.942.323.114.114.24
Net Cash Growth
69.77%-25.39%-24.39%-3.02%162.92%
Net Cash Per Share
0.000.000.000.000.00
Filing Date Shares Outstanding
2,0281,6871,6871,6361,285
Total Common Shares Outstanding
2,0261,6871,6871,5601,285
Working Capital
4.262.233.013.764.03
Book Value Per Share
0.000.000.000.000.00
Tangible Book Value
4.262.233.013.764.03
Tangible Book Value Per Share
0.000.000.000.000.00
Machinery
----0.01